21/03/2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
March 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Feb
Apr »
21/03/2024
Mar 21, 2024, 12:22 |
Blog
OCE Project Community provides information for patients, consumers and caregivers - FDA Oncology
FDA Oncology recently shared a post on X/Twitter: "OCE Project Community provides information for patients,…
Mar 21, 2024, 12:11 |
Blog
Gregg Nelson: Incredibly honoured to receive best paper in Gynecologic Oncology
Gregg Nelson, Professor and Deputy Head of the Department of Obstetrics and Gynecology at the…
Mar 21, 2024, 12:08 |
Blog
Li Ma: In genetically engineered mouse models MALAT1 protects against osteoporosis and bone metastasis
Li Ma, Professor of Experimental Radiation Oncology at MD Anderson Cancer Centre, shared on X/Twitter:…
Mar 21, 2024, 12:00 |
Insight
Fumiko Ladd Chino: Proud of Dr Pooja Karukonda for presenting our Financial Toxicity study of patients with HNCSM receiving radiation
Fumiko Ladd Chino shared a post on X: "Proud of Dr Pooja Karukonda for presenting…
Mar 21, 2024, 10:59 |
Drugs
Guorong Ma: OmniNano Pharmaceuticals announce the execution of the Patent and Technology license with The University of Texas MD Anderson Cancer Center
Guorong Ma, Founding Chief Executive at OmniNano Pharmaceuticals, shared a post on LinkedIn: "At OmniNano…
Mar 21, 2024, 10:54 |
Insight
The Swedish SCAN-B cohort, the HER2DX risk-score was found significantly associated with OS after adjustment for clinical variables and treatment regimen - ESMO Open
ESMO Open posted on X: "Hot off the press: among 757 patients with early HER2+ breast…
Mar 21, 2024, 10:46 |
Insight
Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence - UCLA Health
Drug regimen significantly improves invasive disease-free survival for patients with stage 2 or 3 HR-positive,…
Mar 21, 2024, 09:58 |
Blog
Vivek Subbiah: Presenting the story of Hydra and Cancer
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute in the…
Mar 21, 2024, 09:49 |
Blog
Wafik S. El-Deiry: Wonderful to meet Novocure Executive Chairman William F. Doyle
Wafik S. El-Deiry, the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School…
1
2
All:
19
Posts:
11 - 20
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube